Education
About Us
Working with TipRanks
Follow Us
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
MDGL Analyst Ratings
Strong Buy
13 Buy
1 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MDGL Stock 12 Month Forecast
Average Price Target
$424.21
▲(34.46% Upside)
| Highest Price Target$539.00 | Average Price Target$424.21 | Lowest Price Target$248.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
B.Riley Financial
Reiterated
05/02/25
Leerink Partners
Reiterated
05/01/25
Canaccord Genuity
Reiterated
05/01/25
Bank of America Securities
Reiterated
05/01/25
Cantor Fitzgerald
Reiterated
04/29/25
Jefferies
$398
Buy
26.16%
Upside
Reiterated
04/22/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright
$400→$405
Buy
28.38%
Upside
Reiterated
02/27/25
Madrigal price target raised to $405 from $400 at H.C. WainwrightMadrigal price target raised to $405 from $400 at H.C. Wainwright
Citi
$378→$469
Buy
48.66%
Upside
Reiterated
02/26/25
Analysts' Top Healthcare Picks: BridgeBio Pharma (BBIO), Madrigal Pharmaceuticals (MDGL)We are reiterating our Buy rating and $378 price target for MDGL.O.
Piper Sandler
$336→$400
Buy
26.79%
Upside
Reiterated
02/14/25
Madrigal Pharmaceuticals (MDGL) Receives a Buy from Piper Sandler
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
B.Riley Financial
Reiterated
05/02/25
Leerink Partners
Reiterated
05/01/25
Canaccord Genuity
Reiterated
05/01/25
Bank of America Securities
Reiterated
05/01/25
Cantor Fitzgerald
Reiterated
04/29/25
Jefferies
$398
Buy
26.16%
Upside
Reiterated
04/22/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright
$400→$405
Buy
28.38%
Upside
Reiterated
02/27/25
Madrigal price target raised to $405 from $400 at H.C. WainwrightMadrigal price target raised to $405 from $400 at H.C. Wainwright
Citi
$378→$469
Buy
48.66%
Upside
Reiterated
02/26/25
Analysts' Top Healthcare Picks: BridgeBio Pharma (BBIO), Madrigal Pharmaceuticals (MDGL)We are reiterating our Buy rating and $378 price target for MDGL.O.
Piper Sandler
$336→$400
Buy
26.79%
Upside
Reiterated
02/14/25
Madrigal Pharmaceuticals (MDGL) Receives a Buy from Piper Sandler
Best Analysts Covering Madrigal Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy MDGL and Sell After:
1 Month
xxx
Success Rate
11/14 ratings generated profit
Average Return
+32.04%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 78.57% of your transactions generating a profit, with an average return of +32.04% per trade.
3 Months
xxx
Success Rate
11/14 ratings generated profit
Average Return
+15.89%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 78.57% of your transactions generating a profit, with an average return of +15.89% per trade.
1 Year
2 Years
xxx
Success Rate
21/22 ratings generated profit
Average Return
+111.69%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +111.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MDGL Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
1
2
2
1
0
Buy
21
25
25
16
12
Hold
5
2
2
1
1
Sell
3
3
3
1
1
Strong Sell
2
2
2
0
0
total
32
34
34
19
14
Each month's total comprises the sum of three months' worth of ratings.
MDGL Financial Forecast
MDGL Stock Forecast FAQ
What is MDGL’s average 12-month price target, according to analysts?
Based on analyst ratings, Madrigal Pharmaceuticals Inc’s 12-month average price target is 424.21.
What is MDGL’s upside potential, based on the analysts’ average price target?
Madrigal Pharmaceuticals Inc has 34.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MDGL a Buy, Sell or Hold?
Madrigal Pharmaceuticals Inc has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 1 sell ratings.
What is Madrigal Pharmaceuticals Inc’s price target?
The average price target for Madrigal Pharmaceuticals Inc is 424.21. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $539.00 ,the lowest forecast is $248.00. The average price target represents 34.46% Increase from the current price of $315.48.
The highest analyst price target is $539.00 ,the lowest forecast is $248.00. The average price target represents 34.46% Increase from the current price of $315.48.
What do analysts say about Madrigal Pharmaceuticals Inc?
Madrigal Pharmaceuticals Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of MDGL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.